166 related articles for article (PubMed ID: 37739958)
21. siRNAs target sites selection of ezrin and the influence of RNA interference on ezrin expression and biological characters of osteosarcoma cells.
Shang X; Wang Y; Zhao Q; Wu K; Li X; Ji X; He R; Zhang W
Mol Cell Biochem; 2012 May; 364(1-2):363-71. PubMed ID: 22286748
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic reversal of Huntington's disease by in vivo self-assembled siRNAs.
Zhang L; Wu T; Shan Y; Li G; Ni X; Chen X; Hu X; Lin L; Li Y; Guan Y; Gao J; Chen D; Zhang Y; Pei Z; Chen X
Brain; 2021 Dec; 144(11):3421-3435. PubMed ID: 34918046
[TBL] [Abstract][Full Text] [Related]
23. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
[TBL] [Abstract][Full Text] [Related]
24. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9.
Zhang G; Li M; Jin J; Bai Y; Yang C
Asian Pac J Cancer Prev; 2011; 12(8):2075-80. PubMed ID: 22292654
[TBL] [Abstract][Full Text] [Related]
25. Small extracellular vesicle-mediated
Krishn SR; Garcia V; Naranjo NM; Quaglia F; Shields CD; Harris MA; Kossenkov AV; Liu Q; Corey E; Altieri DC; Languino LR
Cancer Biol Ther; 2022 Dec; 23(1):173-185. PubMed ID: 35188070
[TBL] [Abstract][Full Text] [Related]
26. ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity.
Zucchini C; Manara MC; Cristalli C; Carrabotta M; Greco S; Pinca RS; Ferrari C; Landuzzi L; Pasello M; Lollini PL; Gambarotti M; Donati DM; Scotlandi K
J Exp Clin Cancer Res; 2019 Dec; 38(1):503. PubMed ID: 31878963
[TBL] [Abstract][Full Text] [Related]
27. PAI-1, a target gene of miR-143, regulates invasion and metastasis by upregulating MMP-13 expression of human osteosarcoma.
Hirahata M; Osaki M; Kanda Y; Sugimoto Y; Yoshioka Y; Kosaka N; Takeshita F; Fujiwara T; Kawai A; Ito H; Ochiya T; Okada F
Cancer Med; 2016 May; 5(5):892-902. PubMed ID: 26817521
[TBL] [Abstract][Full Text] [Related]
28. Progression of Osteosarcoma from a Non-Metastatic to a Metastatic Phenotype Is Causally Associated with Activation of an Autocrine and Paracrine uPA Axis.
Endo-Munoz L; Cai N; Cumming A; Macklin R; Merida de Long L; Topkas E; Mukhopadhyay P; Hill M; Saunders NA
PLoS One; 2015; 10(8):e0133592. PubMed ID: 26317203
[TBL] [Abstract][Full Text] [Related]
29. Combination therapy with VEGFR2 and EGFR siRNA enhances the antitumor effect of cisplatin in non-small cell lung cancer xenografts.
Chen S; Liu X; Gong W; Yang H; Luo D; Zuo X; Li W; Wu P; Liu L; Xu Q; Ji A
Oncol Rep; 2013 Jan; 29(1):260-8. PubMed ID: 23117577
[TBL] [Abstract][Full Text] [Related]
30. Mannose-conjugated layered double hydroxide nanocomposite for targeted siRNA delivery to enhance cancer therapy.
Li L; Zhang R; Gu W; Xu ZP
Nanomedicine; 2018 Oct; 14(7):2355-2364. PubMed ID: 28647589
[TBL] [Abstract][Full Text] [Related]
31. Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors.
Ganesh S; Iyer AK; Morrissey DV; Amiji MM
Biomaterials; 2013 Apr; 34(13):3489-502. PubMed ID: 23410679
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic approaches targeting midkine suppress tumor growth and lung metastasis in osteosarcoma.
Sueyoshi T; Jono H; Shinriki S; Ota K; Ota T; Tasaki M; Atsuyama E; Yakushiji T; Ueda M; Obayashi K; Mizuta H; Ando Y
Cancer Lett; 2012 Mar; 316(1):23-30. PubMed ID: 22099874
[TBL] [Abstract][Full Text] [Related]
33. SiRNA-mediated silencing of beta-catenin suppresses invasion and chemosensitivity to doxorubicin in MG-63 osteosarcoma cells.
Zhang F; Chen A; Chen J; Yu T; Guo F
Asian Pac J Cancer Prev; 2011; 12(1):239-45. PubMed ID: 21517265
[TBL] [Abstract][Full Text] [Related]
34. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
[TBL] [Abstract][Full Text] [Related]
35. Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance.
Haghiralsadat F; Amoabediny G; Naderinezhad S; Zandieh-Doulabi B; Forouzanfar T; Helder MN
Int J Nanomedicine; 2018; 13():3853-3866. PubMed ID: 30013340
[TBL] [Abstract][Full Text] [Related]
36. CBX3 predicts an unfavorable prognosis and promotes tumorigenesis in osteosarcoma.
Ma C; Nie XG; Wang YL; Liu XH; Liang X; Zhou QL; Wu DP
Mol Med Rep; 2019 May; 19(5):4205-4212. PubMed ID: 30942427
[TBL] [Abstract][Full Text] [Related]
37. Optimized Cholesterol-siRNA Chemistry Improves Productive Loading onto Extracellular Vesicles.
Haraszti RA; Miller R; Didiot MC; Biscans A; Alterman JF; Hassler MR; Roux L; Echeverria D; Sapp E; DiFiglia M; Aronin N; Khvorova A
Mol Ther; 2018 Aug; 26(8):1973-1982. PubMed ID: 29937418
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of RAC2 by small interfering RNA restrains the progression of osteosarcoma by suppressing the Wnt signaling pathway.
Xia P; Gao X; Shao L; Chen Q; Li F; Wu C; Zhang W; Sun Y
Int J Biol Macromol; 2019 Sep; 137():1221-1231. PubMed ID: 31279058
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the metastatic phenotype of a panel of established osteosarcoma cells.
Ren L; Mendoza A; Zhu J; Briggs JW; Halsey C; Hong ES; Burkett SS; Morrow J; Lizardo MM; Osborne T; Li SQ; Luu HH; Meltzer P; Khanna C
Oncotarget; 2015 Oct; 6(30):29469-81. PubMed ID: 26320182
[TBL] [Abstract][Full Text] [Related]
40. Targeting JNK-interacting-protein-1 (JIP1) sensitises osteosarcoma to doxorubicin.
Posthumadeboer J; van Egmond PW; Helder MN; de Menezes RX; Cleton-Jansen AM; Beliën JA; Verheul HM; van Royen BJ; Kaspers GJ; van Beusechem VW
Oncotarget; 2012 Oct; 3(10):1169-81. PubMed ID: 23045411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
